Sequencing Systemic Therapy in Hepatocellular Carcinoma

Overview of attention for article published in Current Treatment Options in Oncology, October 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#45 of 725)
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 1 news story.

目前多种治疗方案已获批用于不可切除的肝细胞癌（HCC）。当无禁忌证时，应高度考虑将含免疫检查点抑制剂（ICI）的方案作为一线治疗，尤其是对于肝炎病毒相关HCC患者，因为与索拉非尼相比，该方案的总生存期（OS）较优。在所有含ICI的方案中，阿替利珠单抗加贝伐珠…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.